top of page
The Rare360 Editorial Team
Feb 103 min read
FDA's Diversity Guidance Withdrawal Sparks Concerns Over Clinical Trial Inclusivity
In a controversial move, the FDA has quietly removed its draft guidance on clinical trial diversity, sparking concerns over inclusivity.
The Rare360 Editorial Team
Oct 17, 20245 min read
Why Diversity Action Plans in Clinical Trials are Essential for Rare Disease Breakthroughs
Diversity action plans aim to make rare disease clinical trials more inclusive and enhance treatment outcomes.
The Rare360 Editorial Team
Jun 6, 20244 min read
Transforming Rare Disease Research: Insights into Clinical Trial Challenges
Discover the challenges faced by biopharmaceutical companies in rare diseases clinical trials.
The Rare360 Editorial Team
Jan 23, 20244 min read
A Discussion with Michael Kornhauser - A Rare Disease Ally in Clinical Research
Discussing the impact of clinical studies on patients’ lives and Michael’s perspective as a clinical trials operations specialist.
bottom of page